Lords Mark Industries Ltd partners with C-MET for AI-Powered Radiation-Free Breast Cancer Detection Wearable
Lords Mark Industries Ltd has entered into a Technology Transfer Agreement (TTA) with the Centre for Materials for Electronic Technology (C-MET) for the manufacturing and commercialization of an AI-powered, radiation-free wearable device for early detection of breast cancer. The device, which utilizes high-precision thermal sensors and AI-driven temperature mapping, is non-invasive, painless, and eliminates radiation exposure. The global breast cancer diagnostics market is projected to reach approximately USD 12.88 billion by 2035, and this partnership positions the Company at the forefront of the indigenous Med-Tech sector. The product is expected to be available for commercial use globally by the end of the current calendar year.
Key Highlights
- Lords Mark Industries Ltd has partnered with C-MET for the manufacturing and commercialization of an AI-powered, radiation-free breast cancer detection wearable.
- The device utilizes high-precision thermal sensors and AI-driven temperature mapping to detect early-stage abnormalities in a non-invasive and radiation-free manner.
- The global breast cancer diagnostics market is projected to reach approximately USD 12.88 billion by 2035, and this partnership aims to position the Company at the forefront of the indigenous Med-Tech sector.
- The product is expected to be available for commercial use globally by the end of the current calendar year.
- This collaboration integrates C-MET’s scientific expertise with Lords Mark’s manufacturing strength, enabling a new paradigm in preventive diagnostics.